Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsIf Quest Diagnostics makes a killing on this disease,
there had better be a massive investigation eventually.
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
7 replies, 1044 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (12)
ReplyReply to this post
7 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
If Quest Diagnostics makes a killing on this disease, (Original Post)
intrepidity
Mar 2020
OP
RKP5637
(67,111 posts)1. Quest, and LabCorp too. n/t
DonaldsRump
(7,715 posts)2. And who wants to bet the Trump
his family, and/or an entity under his/their control has invested heavily in these companies?!
gibraltar72
(7,506 posts)3. Department of Coincidences needs to look into this.
Bettie
(16,110 posts)4. How much do you think Trump or one of his spawn
will be raking in from this?
gibraltar72
(7,506 posts)5. I'd say it's yuuuuge.
HockeyMom
(14,337 posts)6. No, Rick Scott
or rather his wife.
Ghost Dog
(16,881 posts)7. It says here (Time) :
... When the first cases of COVID-19 were reported in the US, two labs at the CDC were the only ones permitted to conduct COVID-19 testing, using a test developed by the agencys own researchers. When the CDC tried to expand testing by providing its test kits to state and local public health labs, there were problems with the initial version of the kits, which the CDC then reworked.
That delay, along with the growing number of undetected cases in the U.S., prompted the Food and Drug Administration (FDA) on Feb. 29 to expand its approval criteria to allow any qualified lab to develop its own test. Two of the largest diagnostic commercial labs, Quest Diagnostics and LabCorp, have begun testing this week but are still conducting only a few thousand a day as they scale up capacity.
My people have been working all weekend, 24-7, says Dr. Jon Cohen, CEO of BioReference Laboratories, which plans to roll out its test this week. Within a week, if not sooner, we should be able to do 1,000 to 2,000 tests a day, and from there, scale up higher. A spokesperson for North Carolina-based LabCorp says the company has been conducting several thousand tests a day since March 5, and plans to add staff and equipment to increase that number. Quest Diagnostics, based in New Jersey, says the company released its COVID-19 test on March 9, and plans to perform tens of thousands of tests a week within six weeks.
Taken together, thats still a tiny fraction of the number that should be conducted in a country of 327 million people, say experts. As of March 11, CDC, state and public health labs have conducted more than 11,000 tests since mid-January. By comparison, South Korea has tested more than 200,000 of its population of 51 million since January.
In the US, rollout of widespread testing is plagued by not only logistical issues but political over-promising and supply constraints. When the FDA expanded its approval criteria at the end of February, agency commissioner Dr. Stephen Hahn predicted that the policy would lead to enough test kits for more than a million people within a week; when that goal wasnt met, White House Coronavirus Task Force point person Mike Pence was forced to extend the target date by a week as companies scrambled to familiarize themselves with the test and order the chemicals and reagents they needed..
https://www.google.com/url?sa=t&source=web&rct=j&url=https://time.com/5801790/coronavirus-testing-us/%3Famp%3Dtrue&ved=0ahUKEwiVnK6blJboAhUszoUKHXxBARw4ChDIzwEITjAI&usg=AOvVaw3VihbZtb1Q6grqP4R8_sbs&cf=1
That delay, along with the growing number of undetected cases in the U.S., prompted the Food and Drug Administration (FDA) on Feb. 29 to expand its approval criteria to allow any qualified lab to develop its own test. Two of the largest diagnostic commercial labs, Quest Diagnostics and LabCorp, have begun testing this week but are still conducting only a few thousand a day as they scale up capacity.
My people have been working all weekend, 24-7, says Dr. Jon Cohen, CEO of BioReference Laboratories, which plans to roll out its test this week. Within a week, if not sooner, we should be able to do 1,000 to 2,000 tests a day, and from there, scale up higher. A spokesperson for North Carolina-based LabCorp says the company has been conducting several thousand tests a day since March 5, and plans to add staff and equipment to increase that number. Quest Diagnostics, based in New Jersey, says the company released its COVID-19 test on March 9, and plans to perform tens of thousands of tests a week within six weeks.
Taken together, thats still a tiny fraction of the number that should be conducted in a country of 327 million people, say experts. As of March 11, CDC, state and public health labs have conducted more than 11,000 tests since mid-January. By comparison, South Korea has tested more than 200,000 of its population of 51 million since January.
In the US, rollout of widespread testing is plagued by not only logistical issues but political over-promising and supply constraints. When the FDA expanded its approval criteria at the end of February, agency commissioner Dr. Stephen Hahn predicted that the policy would lead to enough test kits for more than a million people within a week; when that goal wasnt met, White House Coronavirus Task Force point person Mike Pence was forced to extend the target date by a week as companies scrambled to familiarize themselves with the test and order the chemicals and reagents they needed..
https://www.google.com/url?sa=t&source=web&rct=j&url=https://time.com/5801790/coronavirus-testing-us/%3Famp%3Dtrue&ved=0ahUKEwiVnK6blJboAhUszoUKHXxBARw4ChDIzwEITjAI&usg=AOvVaw3VihbZtb1Q6grqP4R8_sbs&cf=1
... So, did I miss something? What's new?